The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing biliary tract cancer (BTC) and pancreatic cancer (PC): Outcomes from DESTINY-PanTumor02 (DP-02).
 
Do-Youn Oh
Consulting or Advisory Role - Arcus Biosciences; ASLAN Pharmaceuticals; AstraZeneca; Basilea; Bayer; BeiGene; Celgene; Genentech/Roche; Halozyme; IQVIA; Merck Serono; MSD Oncology; Novartis; Taiho Pharmaceutical; Turning Point Therapeutics; Yuhan; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; BeiGene; Handok; Lilly; MSD; Novartis; SERVIER
 
Iwona A. Lugowska
Honoraria - Agenus; Amgen; AstraZeneca; BeiGene; BMS; Celon Pharma; Cullinan Oncology; Jacobio; Janssen; Loxo; Macrogenics; Menarini; MSD; Pfizer; Rhizen Pharmaceuticals; ROCHE; Sanofi; Sanofi; Takeda
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AGENUS (Inst); ROCHE (Inst)
Travel, Accommodations, Expenses - BMS
 
Daniil Stroyakovskiy
Speakers' Bureau - AstraZeneca; BioCad; Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Roche; Roche
 
Kyung Hae Jung
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bixink; Celgene; Daiichi Sankyo/Astra Zeneca; Eisai; Eisai; Everest Medicine; Merck; MSD; Novartis; Novartis; Pfizer; Roche; Takeda
 
Olivier Dumas
Consulting or Advisory Role - Insyte Consulting
 
Konstantin Penkov
Consulting or Advisory Role - Nektar
Research Funding - AstraZeneca/MedImmune (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Pfizer (Inst); Regeneron (Inst); Roche (Inst)
 
Arunee Dechaphunkul
No Relationships to Disclose
 
Ana Oaknin
Consulting or Advisory Role - AGENUS; AstraZeneca; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo; Debiopharm Group; Deciphera; Eisai; Exelixis; Genmab; GlaxoSmithKline; Immunogen; ITeos Therapeutics; Merck Sharp & Dohme; Mersana; Myriad Genetics; Novocure; OneXerna Therapeutics, Inc.; PharmaMar; Regeneron; Roche; Seagen; Shattuck Labs; Sutro Biopharma; Zentalis
Research Funding - Abbvie (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Bristol-Myers Squibb International Corporation (BMS) (Inst); Clovis Oncology (Inst); Eisai (Inst); Immunogen (Inst); Merck Sharp & Dohme (Inst); Millennium (Inst); PharmaMar (Inst); Regeneron (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; PharmaMar; Roche
 
Seung Tae Kim
No Relationships to Disclose
 
Naureen Starling
Honoraria - Amgen; AstraZeneca; BMS; BMS; GlaxoSmithKline; GlaxoSmithKline; Lilly; Lilly; Merck; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Novartis; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Seagen; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; GlaxoSmithKline; Janssen; MSD; MSD Oncology; MSD Oncology; Novartis Pharmaceuticals UK Ltd.; Pfizer; Seagen; SERVIER
Research Funding - AstraZeneca (Inst); BMS (Inst); Guardant Health (Inst); Merck Serono (Inst); Pfizer/EMD Serono (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Guardant Health; MSD Oncology; SERVIER
(OPTIONAL) Uncompensated Relationships - Guardant Health
 
Busyamas Chewaskulyong
Honoraria - Amgen; AstraZeneca; Eisai; Novartis; Roche; Zuellig Pharma
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; MSD Oncology; Novartis; Pfizer; Roche; Zuellig Pharma
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Pfizer; Eisai; MSD Oncology; Novartis; Roche; Zuellig Pharma
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Eisai; MSD Oncology; Zuellig Pharma
 
Chanchai Charonpongsuntorn
No Relationships to Disclose
 
Deborah Blythe Doroshow
Honoraria - MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Atheneum; Dedham Group; G1 Therapeutics; MJH Life Sciences; Sanofi; Sonata Therapeutics; Summit Therapeutics
Travel, Accommodations, Expenses - MJH Life Sciences
Other Relationship - Bristol Myers Squibb Foundation; Conquer Cancer Foundation
 
Sheng-Yen Hsiao
No Relationships to Disclose
 
Yi-Ping Hung
No Relationships to Disclose
 
Lindsey Jung
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca
 
Nataliya Kuptsova-Clarkson
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Flavia Michelini
Employment - AstraZeneca
 
Soham D. Puvvada
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Funda Meric-Bernstam
Employment - MD Anderson Cancer Center
Honoraria - Dava Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Black Diamond Therapeutics; Calibr; Daiichi Sankyo/Astra Zeneca; EcoR1 Capital; Eisai; Exelixis; GT Aperion; Incyte; Infinity Pharmaceuticals; Karyopharm Therapeutics; LegoChem Biosciences; Lengo Therapeutics; Menarini Group; OnCusp Therapeutics; Protai; Seagen; Tallac Therapeutics; Theratechnologies; Zentalis; Zymeworks
Research Funding - Abbvie (Inst); Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); eFFECTOR Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Jazz Pharmaceuticals (Inst); Klus Pharma (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - ARTIDIS; Cholangiocarcinoma Foundation; Dava Oncology; ESMO; European Organisation for Research and Treatment of Cancer (EORTC)